Purpose. Intramuscular botulinum toxin A (BTA) injection is a local reversible treatment with a wide range of therapeutic applications, including temporary reduction of spasticity. The aim of this work was a quantitative, computerized objective evaluation of BTA-induced improvement of the walking functional ability in a group of children with cerebral palsy (CP). Methods. Fifteen children with CP and 20 healthy children were evaluated. All patients were equinus walkers without fixed contractures of triceps surae muscles and they were evaluated before and after about 1.5 months from BTA injections into the calf muscles. The effectiveness of treatment was evaluated by 3D computerized gait analysis. Results. Data analysis revealed a significan...
Aim This study aimed at comparing two statistical approaches to analyze the effect of Botulinum Toxi...
To evaluate the effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait patt...
AIM To assess treatment effects of botulinum toxin type A (BoNT-A) on walking of children with leg s...
Purpose. Intramuscular botulinum toxin A (BTA) injection is a local reversible treatment with a wide...
Purpose. Intramuscular botulinum toxin A (BTA) injection is a local reversible treatment with a wide...
It is recognized that objective gait analysis is of great value in planning a multilevel botulinum t...
<div><p>Aim</p><p>This study aimed at comparing two statistical approaches to analyze the effect of ...
AIM:This study aimed at comparing two statistical approaches to analyze the effect of Botulinum Toxi...
WOS: 000187502500005PubMed ID: 14643391The current modalities in managing spastic children have some...
AbstractChildren with cerebral palsy who walk with knee flexion during midstance are treated with in...
The objective of this study was to measure the effect of lower extremity multilevel botulinum toxin ...
Purpose Botulinum toxin-A (or Botox) is widely used for the management of equinus gait in children w...
Children with cerebral palsy who walk with knee flexion during midstance are treated with intramuscu...
Botulinum toxin A (BTA) inhibits presynaptic release of acetylcholine at the neuromuscular junction ...
OBJECTIVE: To develop a clinical and instrumental protocol to assess the postural and dynamic effect...
Aim This study aimed at comparing two statistical approaches to analyze the effect of Botulinum Toxi...
To evaluate the effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait patt...
AIM To assess treatment effects of botulinum toxin type A (BoNT-A) on walking of children with leg s...
Purpose. Intramuscular botulinum toxin A (BTA) injection is a local reversible treatment with a wide...
Purpose. Intramuscular botulinum toxin A (BTA) injection is a local reversible treatment with a wide...
It is recognized that objective gait analysis is of great value in planning a multilevel botulinum t...
<div><p>Aim</p><p>This study aimed at comparing two statistical approaches to analyze the effect of ...
AIM:This study aimed at comparing two statistical approaches to analyze the effect of Botulinum Toxi...
WOS: 000187502500005PubMed ID: 14643391The current modalities in managing spastic children have some...
AbstractChildren with cerebral palsy who walk with knee flexion during midstance are treated with in...
The objective of this study was to measure the effect of lower extremity multilevel botulinum toxin ...
Purpose Botulinum toxin-A (or Botox) is widely used for the management of equinus gait in children w...
Children with cerebral palsy who walk with knee flexion during midstance are treated with intramuscu...
Botulinum toxin A (BTA) inhibits presynaptic release of acetylcholine at the neuromuscular junction ...
OBJECTIVE: To develop a clinical and instrumental protocol to assess the postural and dynamic effect...
Aim This study aimed at comparing two statistical approaches to analyze the effect of Botulinum Toxi...
To evaluate the effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait patt...
AIM To assess treatment effects of botulinum toxin type A (BoNT-A) on walking of children with leg s...